A Proprietary Platform for Drug Repurposing Intelligence

Opportunity Identification

We identify existing medicines with potential new-use opportunities based on clinical, scientific, mechanistic, epidemiologic, and commercial signals.

Scientific and Commercial Prioritization

We evaluate whether an opportunity is clinically plausible, commercially meaningful, and suitable for further evidence development.

Evidence Strategy Development

We design structured evidence-generation pathways to support diligence, validation, IP review, and potential commercialization.

Partner-Ready Evidence Packages

We prepare disciplined evidence summaries and strategic materials for confidential partner review.

Commercialization Pathway Planning

We support licensing, co-development, option structures, prospective validation planning, and asset-specific transaction strategies.

Specific methods, protocols, and program-level details are disclosed only under appropriate confidentiality protections.